Review of Ferguson et al "Impact of non-pharmaceutical interventions..."
Sign up for access to the world's latest research
Abstract
Problems with Ferguson et al, owing to scaling and granularity.
Related papers
World Development, 2020
Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
Informed decision-making is increasingly being adopted by global healthcare policy to improve evidence based treatment decisions yet its uptake into clinical practice has been slow. Whilst current clinical practice guidelines and synthesised products (e.g. systematic reviews, evidence summaries) increase access to evidence of treatment effects, they often fail to provide additional information needed to make a fully informed choice. Moreover, a lack of brevity and the use of research jargon are barriers to their implementation in practice. As well as access to information about the benefits and harms of healthcare interventions, consumers also need additional information such as treatment costs, dosage, and the quality of evidence underpinning treatment effects in order to make informed choices. Currently, there are few examples of clinical practice guidelines or synthesised products that present this additional information in one-place and in a concise manner. Here we present such a method and describe how we developed the Evidence of Effects Page. The Evidence of Effects Page is a unique one-page summary of evidence that presents information not only on treatment effects and harms, but also precision of estimates, the quality of evidence and treatment costs. Our methodology can be applied to create additional Evidence of Effects Pages for treatments and interventions for other medical conditions as required. Compared with current products, the Evidence of Effects Page provides additional information for making decisions about healthcare treatments and has potential to facilitate greater adoption of informed decision-making and patient centered care in clinical practice.
Preventing Chronic Disease, 2013
Health Services Research, 2010
Objective. To determine whether investigations of heterogeneity of treatment effects (HTE) in randomized-controlled trials (RCTs) are prespecified and whether authors' interpretations of their analyses are consistent with the objective evidence. Data Sources/Study Setting. We reviewed 87 RCTs that reported formal tests for statistical interaction or heterogeneity (HTE analyses), derived from a probability sample of 541 articles. Data Collection/Extraction. We recorded reasons for performing HTE analysis; an objective classification of evidence for HTE (termed ''clinicostatistical divergence'' [CSD]); and authors' interpretations of findings. Authors' interpretations, compared with CSD, were coded as understated, overstated, or adequately stated. Principle Findings. Fifty-three RCTs (61 percent) claimed prespecified covariates for HTE analyses. Trials showed strong (6), moderate (11), weak (25), or negligible (16) evidence for CSD (29 could not be classified due to inadequate information). Authors stated that evidence for HTE was sufficient to support differential treatment in subgroups (10); warranted more research (31); was absent (21); or provided no interpretation (25). HTE was overstated in 22 trials, adequately stated in 57 trials, and understated in 8 trials. Conclusions. Inconsistencies in performance and reporting may limit the potential of HTE analysis as a tool for identifying HTE and individualizing care in diverse populations. Recommendations for future studies on the reporting and interpretation of HTE analyses are provided.
Journal of Clinical Epidemiology, 2017
DETAILS OF CONTRIBUTORS Study conception and design: The study design was first described in the application to the Patient-Centered Outcomes Research Institute (PCORI) in 2013. Kay Dickersin was the principal investigator and worked with Tianjing Li, Swaroop Vedula, and Peter Doshi to design the study, write the application, and obtain the funding. Evan Mayo-Wilson drafted the protocol with contributions from other authors.
Research on Social Work Practice, 2017
For the past 25 years, I have led multiple group-randomized trials, each focused on a specific underserved population of youth and each one evaluated health effects of complex interventions designed to prevent high-risk behaviors. I share my reflections on issues of intervention and research design, as well as how research results fostered my evolution toward addressing fundamental social determinants of health and well-being. Reflections related to intervention design emphasize the importance of careful consideration of theory of causes and theory of change, theoretical comprehensiveness versus fundamental determinants of population health, how high to reach, and health in all policies. Flowing from these intervention design issues are reflections on implications for research design, including the importance of matching the unit of intervention to the unit of assignment, the emerging field of public health law research, and consideration of design options and design elements beyond...
Canadian Medical Association Journal
is an author of the Template for Invention and Replication checklist. No other competing interests were declared. This article has been peer reviewed.
The American Journal of Occupational Therapy, 2011
Drug and Alcohol Dependence, 2008
Randomized field trials provide unique opportunities to examine the effectiveness of an intervention in real world settings and to test and extend both theory of etiology and theory of intervention. These trials are designed not only to test for overall intervention impact but also to examine how impact varies as a function of individual level characteristics, context, and across time. Examination of such variation in impact requires analytical methods that take into account the trial's multiple nested structure and the evolving changes in outcomes over time. The models that we describe here merge multilevel modeling with growth modeling, allowing for variation in impact to be represented through discrete mixtures-growth mixture models-and nonparametric smooth functions-generalized additive mixed models. These methods are part of an emerging class of multilevel growth mixture models, and we illustrate these with models that examine overall impact and variation in impact. In this paper, we define intent-totreat analyses in group-randomized multilevel field trials and discuss appropriate ways to identify, examine, and test for variation in impact without inflating the Type I error rate. We describe how to make causal inferences more robust to misspecification of covariates in such analyses and how to summarize and present these interactive intervention effects clearly. Practical strategies for reducing model complexity, checking model fit, and handling missing data are discussed using six randomized field trials to show how these methods may be used across trials randomized at different levels.
References (8)
- Ferguson et al., Impact of non-pharmaceutical interventions (NPIs) to re- duce COVID-19 mortality and healthcare demand https://www.imperial. ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/ Imperial-College-COVID19-NPI-modelling-16-03-2020.pdf
- Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) https://www.who.int/docs/default-source/coronaviruse/ who-china-joint-mission-on-covid-19-final-report.pdf
- China Goes Door to Door in Wuhan, Seek- ing Infections https://www.courthousenews.com/ china-goes-door-to-door-in-wuhan-seeking-infections/
- Tracking down Wuhan's new confirmed COVID-19 cases https://www. shine.cn/news/nation/2003023260/
- South Korea pioneers coronavirus drive-through testing station https://www.cnn.com/2020/03/02/asia/ coronavirus-drive-through-south-korea-hnk-intl/index.html
- Daniel Cooney, Vincent Wong, and Yaneer Bar-Yam, Beyond contact tracing: Community-based early detection for Ebola re- sponse, PLoS Currents Outbreaks (May 19, 2016). https://necsi.edu/ beyond-contact-tracing
- Chen Shen and Yaneer Bar-Yam, First thoughts on superspreader events, NECSI (February 28, 2020). https: //necsi.edu/first-thoughts-on-superspreader-events
- Joseph Norman, Yaneer Bar-Yam, and Nassim Nicholas Taleb, Systemic risk of pandemic via novel pathogens-Coronavirus: A note, New Eng- land Complex Systems Institute (January 26, 2020). https://necsi.edu/ systemic-risk-of-pandemic-via-novel-pathogens-coronavirus-a-note